AdaptHealth (AHCO) Stock Forecast & Price Target

$11.00

-0.23 (-2.05%)

(As of 10/1/2024 ET)

AdaptHealth - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 5 Analyst Ratings

Sell
1

Hold
1

Buy
3

Based on 5 Wall Street analysts who have issued ratings for AdaptHealth in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 1 has given a sell rating, 1 has given a hold rating, and 3 have given a buy rating for AHCO.

Consensus Price Target

$10.70
-2.73% Downside

According to the 5 analysts' twelve-month price targets for AdaptHealth, the average price target is $10.70. The highest price target for AHCO is $13.00, while the lowest price target for AHCO is $6.50. The average price target represents a forecasted downside of -2.73% from the current price of $11.00.

Get the Latest News and Ratings for AHCO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for AdaptHealth and its competitors.

AHCO Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$10.70	$10.70	$12.42	$18.92
Forecasted Upside	-2.73% Downside	-2.64% Downside	28.01% Upside	110.95% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

Next Week Elon Could Trigger a Boom in this Sub-$3 Stock (Ad)

Next week, you’ll have a chance to get in on the ground floor of what could be Elon’s next big thing. You see, he’s set to reveal his new AI product that I believe will shock the world…

Click here to see the details and save your seat.

AHCO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AHCO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

AdaptHealth Stock vs. The Competition

Type	AdaptHealth	Medical Companies	S&P 500
Consensus Rating Score	2.40	2.78	2.50
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	-2.73% Downside	813.43% Upside	6.86% Upside
News Sentiment Rating	Positive News See Recent AHCO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/12/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$13.00 ➝ $13.00	+38.00%
5/15/2024	Truist Financial 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$13.00 ➝ $13.00	+31.18%
2/28/2024	UBS Group 4 of 5 stars		Boost Target	Buy ➝ Buy	$9.00 ➝ $13.00	+27.70%
1/8/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$14.50 ➝ $8.00	+11.89%
11/8/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform	$9.50 ➝ $6.50	-15.47%
7/13/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$20.00 ➝ $21.00	+64.84%
5/10/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$28.00 ➝ $11.30
5/9/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$18.00 ➝ $11.00	-2.65%
3/1/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$30.00 ➝ $23.00	+47.53%
11/10/2022	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform	$29.00 ➝ $30.00	+44.79%
11/9/2022	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$26.00 ➝ $28.00	+29.63%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:30 PM ET.

AHCO Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for AdaptHealth is $10.70, with a high forecast of $13.00 and a low forecast of $6.50.
: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There is currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares.
: According to analysts, AdaptHealth's stock has a predicted downside of -2.73% based on their 12-month stock forecasts.
: AdaptHealth has been rated by research analysts at Royal Bank of Canada in the past 90 days.
: Analysts like AdaptHealth less than other "medical" companies. The consensus rating for AdaptHealth is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AHCO compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Next Week Elon Could Trigger a Boom in this Sub-$3 Stock (Ad)

Next week, you’ll have a chance to get in on the ground floor of what could be Elon’s next big thing. You see, he’s set to reveal his new AI product that I believe will shock the world…

Click here to see the details and save your seat.

This page (NASDAQ:AHCO) was last updated on 10/1/2024 by MarketBeat.com Staff

From Our Partners